Mach7 Technologies
Mach7 Technologies specializes in enterprise image management systems, providing healthcare organizations with the ability to identify, connect, and share diagnostic images and patient care intelligence efficiently. The company positions itself as a definitive technology partner, offering flexible solutions that integrate seamlessly with existing healthcare infrastructures.
Short position
Mach7 Technologies (ASX:M7T) has 0.00% of its shares on issue reported as short positions as of 23 Sept 2026, or about 1,893 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.50% in July 2022. M7T is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Mach7 Technologies (M7T) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXNotification of cessation of securities - M7T
other announcement
Google NewsMach7 Technologies (ASX:M7T): Can Recurring Revenue Define Its FY27 Reset? - Kalkine
Mach7 Technologies (ASX:M7T): Can Recurring Revenue Define Its FY27 Reset? Kalkine
Notification of cessation of securities - M7T
other announcement
Preliminary Final Report and Audited Financial Statements
other announcement
KalkineMach7 Technologies Announces FY26 Full-Year Financial Results Release on 28 August 2026
Mach7 Technologies (ASX:M7T), a healthcare software provider specializing in enterprise imaging solutions, has announced it will publish its full-year financial results for the fiscal year ending 30 June 2026 on 28 August 2026. This will be followed by an investor webinar led by the company’s CEO and CFO. Key Points Mach7 Technologies to release FY26 full-year results on 28 August 2026 Financial results pertain to the year ended 30 June 2026 CEO Teri Thomas and CFO Shawni Hadfield to conduc...
Why Is Mach7 Technologies (ASX:M7T) Drawing Market Attention?
Highlights Mach7 Technologies (ASX:M7T) extends robust share price recovery rally demonstrating healthcare technology sector strength and recovery momentum Medical imaging software provider demonstrates business model resilience and market opportunity validation through valuation recovery Healthcare technology sector attracts investor attention as digital transformation opportunities become increasingly evident Mach7 Technologies (ASX:M7T) continued its impressive share price recovery rally i...
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
Why Mach7 Technologies Could Rebound Strongly Soon
Highlights Healthcare imaging demand continues to reshape digital solutions Recurring revenue model gaining traction across global markets Strong balance sheet supports long-term strategic execution The Australian healthcare technology space continues to draw attention across the broader ASX stock market, where innovation and recurring revenue models are shaping future growth narratives. Among emerging players, Mach7 Technologies Ltd (M7T) stands out as a specialised medical imaging software ...
Healthcare Sector Update: Is Mach7 Technologies (ASX:M7T) on ASX 300 Radar?
Highlights Mach7 Technologies operates in medical imaging software. Enterprise imaging solutions support healthcare systems. Sector activity highlights digital healthcare transformation. Mach7 Technologies Ltd remains active in the ASX healthcare sector, focusing on enterprise imaging solutions and digital health systems within Australia’s evolving healthcare landscape. The healthcare technology sector remains a vital part of Australian equities, with companies listed across indic...